Literature DB >> 32209253

Efficacy of osimertinib in a patient with leptomeningeal metastasis and EGFR uncommon S768I mutation.

Takae Okuno1, Sayaka Arakawa1, Tatsuya Yoshida2, Yuichiro Ohe1.   

Abstract

Entities:  

Keywords:  EGFR uncommon mutation; Epidermal growth factor receptor (EGFR) mutation; Leptomeningeal metastasis; Non-small cell lung cancer; Osimertinib; S768I

Mesh：

Substances：

Year:  2020        PMID： 32209253     DOI： 10.1016/j.lungcan.2020.03.016

Source DB:  PubMed          Journal:  Lung Cancer        ISSN： 0169-5002            Impact factor:   5.705


× No keyword cloud information.
  1 in total

1.  EGFR uncommon alterations in advanced non-small cell lung cancer and structural insights into sensitivity to diverse tyrosine kinase inhibitors.

Authors:  Haiyan Xu; Guangjian Yang; Runze Liu; Yaning Yang; Weihua Li; Junling Li; Xuezhi Hao; Puyuan Xing; Yan Wang
Journal:  Front Pharmacol       Date:  2022-09-16       Impact factor: 5.988
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.